Scgb1b3, a member of the secretoglobin family, plays a pivotal role in cellular processes by virtue of its predicted steroid binding activity and extracellular localization. This multifaceted protein, encoded by the Scgb1b3 gene, is integral to the modulation of steroid responses within the cellular environment. Its predicted activity in the extracellular region implies interactions with external factors, potentially participating in intercellular signaling or communication. Understanding the functional significance of Scgb1b3 is paramount for unraveling its role in cellular homeostasis and response to various stimuli. The activation mechanisms of Scgb1b3 involve intricate regulatory networks and pathways that modulate its expression and function. One of the primary routes involves the up-regulation of Scgb1b3 through the stimulation of adenylate cyclase, leading to increased levels of cyclic AMP (cAMP). Elevated cAMP levels, in turn, activate protein kinase A (PKA), initiating a cascade that positively influences the expression of Scgb1b3. Epigenetic regulation also plays a crucial role, with histone deacetylase (HDAC) inhibitors inducing histone hyperacetylation and favorably impacting Scgb1b3 transcription. Sirtuins, activated by certain compounds, contribute to Scgb1b3 activation through deacetylation processes, underscoring the involvement of post-translational modifications in its regulation.
Disruption of signaling pathways such as TGF-β, PI3K/AKT, and MAPK/ERK influences Scgb1b3 indirectly. Inhibitors targeting these pathways prevent repression or modulation of Scgb1b3, leading to enhanced gene expression and protein activation. The intricate interplay between these pathways reflects the sophisticated regulatory network governing Scgb1b3, allowing for a nuanced response to diverse cellular cues. Overall, the multifaceted nature of Scgb1b3 activation suggests its involvement in a wide array of cellular processes, with its functional significance extending beyond steroid binding to encompass complex interactions within cellular signaling networks. Deciphering these activation mechanisms provides valuable insights into the regulatory landscape of Scgb1b3 and its potential implications in cellular physiology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenol, modulates SIRT1 activity and promotes Scgb1b3 expression. SIRT1 deacetylates specific targets, indirectly enhancing the activation of the Scgb1b3 gene. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, an HDAC inhibitor, induces histone hyperacetylation, positively affecting Scgb1b3 transcription. This epigenetic modulation leads to increased gene expression and protein activation. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, a form of vitamin B3, activates sirtuins, influencing Scgb1b3 through deacetylation. Sirtuin-mediated regulation enhances the activity of Scgb1b3 in response to cellular cues. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542, a TGF-β receptor inhibitor, disrupts TGF-β signaling pathways, indirectly preventing TGF-β-mediated repression of Scgb1b3, resulting in increased gene expression and protein activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, attenuates the PI3K/AKT pathway, indirectly influencing Scgb1b3 activation. Disruption of this pathway leads to altered downstream signaling, positively affecting Scgb1b3. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a BET bromodomain inhibitor, modulates epigenetic regulation by targeting BRD4. This intervention indirectly promotes Scgb1b3 expression, as BRD4 inhibition alters chromatin structure favorably. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a MEK inhibitor, disrupts the MAPK/ERK pathway, indirectly affecting Scgb1b3 activation. Altered MAPK signaling results in modified transcription factors, positively influencing Scgb1b3. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, hinders PI3K activity, indirectly influencing Scgb1b3. Impaired PI3K signaling leads to downstream effects that positively impact the activation of Scgb1b3. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, an HDAC inhibitor, induces histone hyperacetylation, positively affecting Scgb1b3 transcription. This epigenetic modulation leads to increased gene expression and protein activation. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A-769662, an AMPK activator, stimulates AMPK activity, leading to increased Scgb1b3 expression. Activated AMPK positively influences the cellular environment, favoring the up-regulation of Scgb1b3. | ||||||